CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 48 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $23,934,000 | +77.4% | 3,296,752 | +58.9% | 0.00% | +33.3% |
Q3 2016 | $13,490,000 | +27.2% | 2,075,321 | +6.8% | 0.00% | +50.0% |
Q2 2016 | $10,607,000 | +40.5% | 1,942,735 | +20.4% | 0.00% | 0.0% |
Q1 2016 | $7,549,000 | -9.6% | 1,613,004 | -3.8% | 0.00% | 0.0% |
Q4 2015 | $8,349,000 | +37.4% | 1,676,506 | +3.7% | 0.00% | 0.0% |
Q3 2015 | $6,077,000 | -38.1% | 1,616,279 | -1.0% | 0.00% | 0.0% |
Q2 2015 | $9,816,000 | +17.9% | 1,633,218 | +9.8% | 0.00% | 0.0% |
Q1 2015 | $8,329,000 | +86.0% | 1,487,264 | -0.4% | 0.00% | +100.0% |
Q4 2014 | $4,479,000 | +28.2% | 1,492,901 | +14.5% | 0.00% | 0.0% |
Q3 2014 | $3,494,000 | -8.2% | 1,303,668 | -4.1% | 0.00% | 0.0% |
Q2 2014 | $3,805,000 | -41.4% | 1,359,091 | -8.7% | 0.00% | -50.0% |
Q1 2014 | $6,489,000 | +40.0% | 1,488,215 | +3.1% | 0.00% | +100.0% |
Q4 2013 | $4,634,000 | +93.1% | 1,443,635 | -4.3% | 0.00% | 0.0% |
Q3 2013 | $2,400,000 | +3.9% | 1,509,139 | +13.1% | 0.00% | 0.0% |
Q2 2013 | $2,309,000 | – | 1,334,451 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |